SE0401001D0 - Chemical process - Google Patents

Chemical process

Info

Publication number
SE0401001D0
SE0401001D0 SE0401001A SE0401001A SE0401001D0 SE 0401001 D0 SE0401001 D0 SE 0401001D0 SE 0401001 A SE0401001 A SE 0401001A SE 0401001 A SE0401001 A SE 0401001A SE 0401001 D0 SE0401001 D0 SE 0401001D0
Authority
SE
Sweden
Prior art keywords
alkyl
compound
formula
chemical process
haloalkyl
Prior art date
Application number
SE0401001A
Other languages
English (en)
Swedish (sv)
Inventor
Ulf Larsson
Kajsa Raadevik
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0401001A priority Critical patent/SE0401001D0/xx
Publication of SE0401001D0 publication Critical patent/SE0401001D0/xx
Priority to CA2560094A priority patent/CA2560094C/en
Priority to PT05729737T priority patent/PT1751117E/pt
Priority to SG200902108-0A priority patent/SG151311A1/en
Priority to PL05729737T priority patent/PL1751117T3/pl
Priority to NZ587999A priority patent/NZ587999A/en
Priority to PCT/GB2005/001188 priority patent/WO2005095358A2/en
Priority to EP05729737A priority patent/EP1751117B1/de
Priority to CN201010206146A priority patent/CN101851212A/zh
Priority to KR1020067021443A priority patent/KR101164265B1/ko
Priority to SI200531366T priority patent/SI1751117T1/sl
Priority to JP2007505626A priority patent/JP5059599B2/ja
Priority to AT05729737T priority patent/ATE517096T1/de
Priority to US10/599,377 priority patent/US7799914B2/en
Priority to AU2005227727A priority patent/AU2005227727B2/en
Priority to ES05729737T priority patent/ES2368069T3/es
Priority to DK05729737.6T priority patent/DK1751117T3/da
Priority to EP10179703A priority patent/EP2308853A1/de
Priority to BRPI0509323-6A priority patent/BRPI0509323A/pt
Priority to NZ550128A priority patent/NZ550128A/en
Priority to CN2005800102841A priority patent/CN1938284B/zh
Priority to IL177998A priority patent/IL177998A/en
Priority to NO20064117A priority patent/NO20064117L/no
Priority to ZA200607708A priority patent/ZA200607708B/en
Priority to HK07108017.5A priority patent/HK1103727A1/xx
Priority to US12/871,993 priority patent/US20100324289A1/en
Priority to HR20110658T priority patent/HRP20110658T1/hr
Priority to CY20111100890T priority patent/CY1111847T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE0401001A 2004-03-31 2004-03-31 Chemical process SE0401001D0 (sv)

Priority Applications (28)

Application Number Priority Date Filing Date Title
SE0401001A SE0401001D0 (sv) 2004-03-31 2004-03-31 Chemical process
CN2005800102841A CN1938284B (zh) 2004-03-31 2005-03-29 化学方法
AT05729737T ATE517096T1 (de) 2004-03-31 2005-03-29 Verfahren zur herstellung von aminopyrimidinen
AU2005227727A AU2005227727B2 (en) 2004-03-31 2005-03-29 Process for the preparation of aminopyrimidines
SG200902108-0A SG151311A1 (en) 2004-03-31 2005-03-29 Process for the preparation of aminopyrimidines
PL05729737T PL1751117T3 (pl) 2004-03-31 2005-03-29 Sposób wytwarzania aminopirymidyn
NZ587999A NZ587999A (en) 2004-03-31 2005-03-29 Process for the preparation of aminopyrimidines
PCT/GB2005/001188 WO2005095358A2 (en) 2004-03-31 2005-03-29 Process for the preparation of aminopyrimidines
EP05729737A EP1751117B1 (de) 2004-03-31 2005-03-29 Verfahren zur herstellung von aminopyrimidinen
CN201010206146A CN101851212A (zh) 2004-03-31 2005-03-29 化学方法
KR1020067021443A KR101164265B1 (ko) 2004-03-31 2005-03-29 아미노피리미딘의 제조방법
SI200531366T SI1751117T1 (sl) 2004-03-31 2005-03-29 Postopek za pripravo aminopirimidinov
JP2007505626A JP5059599B2 (ja) 2004-03-31 2005-03-29 化学的工程
CA2560094A CA2560094C (en) 2004-03-31 2005-03-29 Process for the preparation of aminopyrimidines
US10/599,377 US7799914B2 (en) 2004-03-31 2005-03-29 Chemical process
PT05729737T PT1751117E (pt) 2004-03-31 2005-03-29 Processo para a preparação de aminopirimidinas
ES05729737T ES2368069T3 (es) 2004-03-31 2005-03-29 Procedimiento para la preparación de aminopirimidinas.
DK05729737.6T DK1751117T3 (da) 2004-03-31 2005-03-29 Fremgangsmåde til fremstilling af aminopyrimidiner
EP10179703A EP2308853A1 (de) 2004-03-31 2005-03-29 Verfahren zur Herstellung von Aminopyrimidinen
BRPI0509323-6A BRPI0509323A (pt) 2004-03-31 2005-03-29 processo para a preparação de um composto
NZ550128A NZ550128A (en) 2004-03-31 2005-03-29 Process for the preparation of aminopyrimidines
IL177998A IL177998A (en) 2004-03-31 2006-09-11 Process for the preparation of 5-aminopyrimidines
NO20064117A NO20064117L (no) 2004-03-31 2006-09-13 Kjemisk prosess
ZA200607708A ZA200607708B (en) 2004-03-31 2006-09-14 Process for the preparation of aminopyrimidines
HK07108017.5A HK1103727A1 (en) 2004-03-31 2007-07-24 Process for the preparation of aminopyrimidines
US12/871,993 US20100324289A1 (en) 2004-03-31 2010-08-31 Chemical Process
HR20110658T HRP20110658T1 (hr) 2004-03-31 2011-09-13 Postupak za pripravu aminopirimidina
CY20111100890T CY1111847T1 (el) 2004-03-31 2011-09-15 Διαδικασια για την παρασκευη αμινοπυριμιδινων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0401001A SE0401001D0 (sv) 2004-03-31 2004-03-31 Chemical process

Publications (1)

Publication Number Publication Date
SE0401001D0 true SE0401001D0 (sv) 2004-03-31

Family

ID=32294337

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0401001A SE0401001D0 (sv) 2004-03-31 2004-03-31 Chemical process

Country Status (24)

Country Link
US (2) US7799914B2 (de)
EP (2) EP1751117B1 (de)
JP (1) JP5059599B2 (de)
KR (1) KR101164265B1 (de)
CN (2) CN101851212A (de)
AT (1) ATE517096T1 (de)
AU (1) AU2005227727B2 (de)
BR (1) BRPI0509323A (de)
CA (1) CA2560094C (de)
CY (1) CY1111847T1 (de)
DK (1) DK1751117T3 (de)
ES (1) ES2368069T3 (de)
HK (1) HK1103727A1 (de)
HR (1) HRP20110658T1 (de)
IL (1) IL177998A (de)
NO (1) NO20064117L (de)
NZ (2) NZ550128A (de)
PL (1) PL1751117T3 (de)
PT (1) PT1751117E (de)
SE (1) SE0401001D0 (de)
SG (1) SG151311A1 (de)
SI (1) SI1751117T1 (de)
WO (1) WO2005095358A2 (de)
ZA (1) ZA200607708B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401001D0 (sv) * 2004-03-31 2004-03-31 Astrazeneca Ab Chemical process
CA2636619A1 (en) * 2006-02-13 2007-08-23 Lonza Ag Reduction of 5-(aryl-diazenyl)-4,6-dihalo-pyrimidine
WO2010030224A1 (en) 2008-09-09 2010-03-18 Astrazeneca Ab A process for preparing [1s- [1-alpha, 2-alpha, 3-beta (1s*, 2r*) 5-beta] ] -3- [7- [2- (3, 4-dif luorophenyl) -cyclopropylamino] - 5- (propylthio) -3h-1, 2, 3-triazolo [4, 5-d] pyrimidin-3-yl] -5- (2- hydroxyethoxy) cyclopentane-1, 2-diol and to its intermediates
EP2305376A1 (de) * 2009-09-23 2011-04-06 Lonza Ltd. Prozess und Katalysator zur katalytischen Hydrierung von aromatischen und heteroaromatischen Nitroverbindungen
US9233966B2 (en) 2012-04-05 2016-01-12 Dr. Reddy's Laboratories Limited Preparation of ticagrelor
CN103130726A (zh) * 2013-02-07 2013-06-05 许学农 替卡格雷中间体4,6-二氯-2-(丙巯基)-5-氨基嘧啶的制备方法
WO2014206187A1 (zh) 2013-06-24 2014-12-31 苏州明锐医药科技有限公司 替卡格雷及其中间体的制备方法
CN105705499B (zh) * 2013-08-22 2018-10-12 基因泰克公司 用于制备化合物的方法
CN103588712B (zh) * 2013-11-08 2016-06-08 南京欧信医药技术有限公司 一种嘧啶类化合物及其制备方法、和应用
CN103923020A (zh) * 2014-04-02 2014-07-16 黄河三角洲京博化工研究院有限公司 一种2-丙硫基-4,6-二氯-5-氨基嘧啶的制备方法
CN105020602B (zh) * 2014-04-30 2017-12-08 欧普照明股份有限公司 一种led灯
CN103992277A (zh) * 2014-05-16 2014-08-20 苏州天马精细化学品股份有限公司 一种替卡格雷中间体4,6-二氯-5-氨基-2-丙硫基嘧啶的制备方法
CN105294573B (zh) * 2015-06-16 2018-07-10 厦门医学院 一种合成4,6-二氯-2-(丙硫基)-5-氨基嘧啶的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3141028B2 (ja) * 1991-04-06 2001-03-05 アストラ・フアーマシユウテイカルズ・リミテツド Ａｔｐ類似体
KR100400419B1 (ko) 1995-05-19 2003-12-18 신젠타 파티서페이션즈 아게 방향족니트로화합물의촉매적수소화방법
TW530058B (en) 1997-07-22 2003-05-01 Astra Pharma Prod Triazolo [4,5-d]pyrimidine compounos and their use and process for preparation
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013488D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Chemical compound
US6818720B2 (en) * 2001-11-08 2004-11-16 Degussa Ag Supported hydrogenating catalyst in powder form
SE0401001D0 (sv) * 2004-03-31 2004-03-31 Astrazeneca Ab Chemical process

Also Published As

Publication number Publication date
US20070219371A1 (en) 2007-09-20
CA2560094C (en) 2012-10-30
US20100324289A1 (en) 2010-12-23
BRPI0509323A (pt) 2007-09-04
US7799914B2 (en) 2010-09-21
EP1751117B1 (de) 2011-07-20
CN1938284A (zh) 2007-03-28
WO2005095358A2 (en) 2005-10-13
ATE517096T1 (de) 2011-08-15
IL177998A0 (en) 2006-12-31
HRP20110658T1 (hr) 2011-10-31
NZ550128A (en) 2010-10-29
DK1751117T3 (da) 2011-10-10
IL177998A (en) 2012-03-29
JP5059599B2 (ja) 2012-10-24
CN1938284B (zh) 2010-08-11
ZA200607708B (en) 2008-06-25
AU2005227727B2 (en) 2009-03-26
EP1751117A2 (de) 2007-02-14
SI1751117T1 (sl) 2011-10-28
KR101164265B1 (ko) 2012-07-09
SG151311A1 (en) 2009-04-30
CY1111847T1 (el) 2015-10-07
CN101851212A (zh) 2010-10-06
PL1751117T3 (pl) 2011-11-30
EP2308853A1 (de) 2011-04-13
ES2368069T3 (es) 2011-11-14
NZ587999A (en) 2012-04-27
PT1751117E (pt) 2011-09-19
HK1103727A1 (en) 2007-12-28
CA2560094A1 (en) 2005-10-13
WO2005095358A3 (en) 2006-01-05
JP2007530650A (ja) 2007-11-01
NO20064117L (no) 2006-10-30
KR20060133019A (ko) 2006-12-22
AU2005227727A1 (en) 2005-10-13

Similar Documents

Publication Publication Date Title
HK1103727A1 (en) Process for the preparation of aminopyrimidines
JP2008523069A5 (de)
TW200744994A (en) Insecticidal 3-acylaminobenzanilides
EA200701470A1 (ru) Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений
DE602007011231D1 (de) Triazolonderivat
DE60205769D1 (de) Verfahren zur herstellung von amphetaminen aus phenylpropanolaminen
AR051936A1 (es) Proceso para la preparacion de pirazoles
ATE531689T1 (de) Cycloalkyliden- (ortho-substituiertes phenyl)- acetonitrile und ihre verwendung als geruchsstoffe
TW200704632A (en) Process for the preparation of 1-[cyano(4-hydroxyphenyl)methyl]cyclohexanol compounds
CO5640113A2 (es) Amidas de acido pieprazinil o piepridinilamin-sulfamico como inhibidores de la sulfatasa esteroidal
DE60325631D1 (de) Verfahren zur herstellung von 2,6-dihalo-para-trifluoromethylanilin
DE602005022213D1 (de) Verfahren zur herstellung von phenyl-2-pyrimidinyl-ketonen und neuen zwischenprodukten daraus
DE602005001704D1 (de) Verfahren zur herstellung von alkoxycarbonylmethoxy-cyclopentanen
DE60314167D1 (de) Verfahren zur herstellung von fluorhalogenalkanen
CR7832A (es) Tritiocarbonatos de cianometilo como nematicidas
UY28512A1 (es) Difluoralquenos nematicidas
NO20070610L (no) Fremgangsmate for fremstilling av synteseintermediater anvendelige ved fremstilling av pyrazolforbindelser.
TW200730495A (en) Process for producing 2-oxindole compound
ATE481390T1 (de) Pyrazolverbindung
DE60222536D1 (de) Verfahren zur herstellung von 1-chlor-4-arylbutan
TH82166B (th) กระบวนการที่ดีขึ้นสำหรับการเตรียมไดไฮโดรเบนโซฟิวแรนที่ถูกแทนที่ด้วย(โพรพีนิลที่ถูกแทนที่สองตำแหน่ง)เฟนิลแอลคิล
TH86039A (th) กรรมวิธีสำหรับการเตรียมสารประกอบ 1-[ไซยาโน(4-ไฮดรอกซีฟีนิล)เมธิล]ไซโคลเฮกซานอล
TH68954A (th) อนุพันธุ์ไซคลิกที่ถูกแทนที่ด้วยฟีนิล
TH86039B (th) กรรมวิธีสำหรับการเตรียมสารประกอบ 1-[ไซยาโน(4-ไฮดรอกซีฟีนิล)เมธิล]ไซโคลเฮกซานอล
TH88614A (th) สารประกอบใหม่